Brief: Enlivex Says Israeli Ministry Of Health Authorizes Initiation Of Phase II Clinical Trial Evaluating Allocetra
13/10/2020 14:47
Oct 13 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX: AFTER EXPEDITED REVIEW, ISRAELI MINISTRY OF
HEALTH
AUTHORIZES INITIATION OF PHASE II CLINICAL TRIAL EVALUATING
ALLOCETRA IN COVID-19 SEVERE AND CRITICAL PATIENTS
* ENLIVEX THERAPEUTICS LTD - PHASE II TRIAL IS EXPECTED TO
RECRUIT
UP TO 24 COVID-19 PATIENTS IN SEVERE OR CRITICAL CONDITION
Source text for Eikon: ID:nGNXbPCcyG
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment